Discontinued — last reported Q4 '25
Labcorp Holdings Commercial Paper Outstanding increased by 4.0% to $107.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.5%, from $102.80M to $107.40M. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels indicate reliance on short-term funding, which may increase sensitivity to interest rate fluctuations.
This represents the total aggregate principal amount of short-term, unsecured promissory notes issued by the company to...
Common for large corporations with high credit ratings and consistent cash flow needs.
commercial_paper_outstanding| Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.40M | $79.80M | $84.50M | $84.70M | $85.40M | $90.70M | $90.70M | $91.90M | $102.80M | $103.30M | $103.30M | $107.40M |
| QoQ Change | — | +4.5% | +5.9% | +0.2% | +0.8% | +6.2% | +0.0% | +1.3% | +11.9% | +0.5% | +0.0% | +4.0% |
| YoY Change | — | — | — | +10.9% | +7.0% | +7.3% | +7.1% | +7.6% | +13.3% | +13.9% | +12.4% | +4.5% |